Annette Marleau, Ph.D.

Chief Technology Officer

Dr. Marleau is an immunologist with over 15 years of experience in devising and managing R&D programs to support the advancement of therapeutic candidates for immune related diseases. She previously held leadership positions in private and public immuno-oncology companies and research institutions. She has been the Principal Investigator for federally funded initiatives directed toward developing novel technologies for liquid biopsy-based diagnostics and extracorporeal therapies for cancer. She previously co-founded a consulting group that provided strategic and scientific input for new product development programs, regulatory submissions, and IP portfolio expansion for pharmaceutical and biotech companies. Her expertise spans numerous areas including infectious diseases, neurological disorders, and regenerative medicine. Dr. Marleau completed a fellowship in immunology at Scripps Research in La Jolla, CA where she specialized in autoimmune disorders. She is a graduate of Western University (Ph.D.), Ontario Veterinary College/University of Guelph (M.S.), and University of Waterloo (B.S.) in Canada.